October 25, 2010 (FinancialWire) (Investrend Forums Syndicate) (Go to http://www.financialwire.net/?s=prsnttnsntt for other company presentation articles.) — Apricus Biosciences, Inc. (APRI), a biotechnology company that develops pharmaceutical delivery products, will be presenting at the Financial Services Exchange (“FSX”) conference being held in Phoenix, Arizona this week. The FSX event is scheduled over a three-day period, from October 28th through 30th, at the Ritz Carlton. Complete conference details are posted on the FSX website (at http://www.fsx1.com/).

Apricus Biosciences engages in designing and developing pharmaceutical products based on its patented drug delivery technology, designed to enhance the delivery of an active drug to improve therapeutic outcomes and reduce systemic side effects that accompany oral and injectable medications. Further, the company, through its subsidiary, Bio-Quant, Inc., operates as a specialty biotech contract research organization that provides services in the areas of non-good laboratory practices in vitro and in vivo contract drug discovery, as well as pre-clinical development services specializing in oncology, inflammation, immunology, and metabolic diseases. The company was founded in 1987 and is headquartered in San Diego, California.

Other companies presenting at the event include Atossa Genetics, Inc., and Capital Group Holdings, Inc.

Atossa Genetics is a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer. Atossa is being sponsored at the event by Seattle, Washington-based Dawson James Securities.

Capital Group Holdings is a company focused on developing and executing initiatives in the Health 2.0 space. The company acquires and promotes institutions rooted in the health and wellness industry, and is based in Scottsdale, Arizona.

=========

Resource note: Participation in FSX events via Investrend Forums includes enhancement platforms for event participants, as well as other applicable special programs. For information, email resources@investrend.com, with the "FSX Inquiry" in the subject line.

=========

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ftrdnwswnd] [ssryrsyr] [cnfrncvntprsntn] [prsnttnsntt] [pltfrm] [bsdarrgnmnt] [fnsrvcsxchng] [synd0010] [aprinas]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.